Effects of diltiazem, a Ca2+ channel blocker, on naloxone-precipitated changes in dopamine and its metabolites in the brains of opioid-dependent rats

Psychopharmacology

Volumn 125, Issue 2, 1996, Pages 135-140

  Tokuyama, Shogo ^a   Ho, Ing K ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Butorphanol; Ca2+ channel; Diltiazem; Dopamine; HPLC ED; Morphine; Opioid dependence

Indexed keywords

BUTORPHANOL; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; DOPAMINE; MORPHINE; NALOXONE; NARCOTIC AGENT; NARCOTIC ANTAGONIST; 3,4 DIHYDROXYPHENYLACETIC ACID; CALCIUM; CALCIUM CHANNEL; HOMOVANILLIC ACID; MU OPIATE RECEPTOR AGONIST; OPIATE AGONIST;

ANIMAL; ARTICLE; BRAIN; BRAIN CORTEX; COMPARATIVE STUDY; CORPUS STRIATUM; DRUG EFFECT; MALE; MESENCEPHALON; METABOLISM; RAT; SPRAGUE DAWLEY RAT; WITHDRAWAL SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BRAIN REGION; CALCIUM CELL LEVEL; CONTROLLED STUDY; DOPAMINE METABOLISM; DRUG ANTAGONISM; ELECTROCHEMICAL DETECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; LIMBIC SYSTEM; NONHUMAN; OPIATE ADDICTION; PRIORITY JOURNAL;

ANIMALS; BRAIN; BUTORPHANOL; CALCIUM CHANNEL BLOCKERS; CEREBRAL CORTEX; CORPUS STRIATUM; DILTIAZEM; DOPAMINE; MALE; MESENCEPHALON; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; NARCOTICS; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0029659020     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02249412     Document Type: Article

References (43)

1. Akaike N, Kostyuk PG, Osipchuk YV (1989) Dihydropyridine-sensitive low-threshold calcium channels in isolated rat hypothalamic neurones. J Physiol 412:181-195
2. Atkinson J, Lambas-Senas L, Parker M, Boillat N, Luthi P, Sonnay M, Seccia M, Renaud B (1986) Chronic clonidine treatment and its withdrawal: effects on blood pressure and catecholamine synthesizing enzymes in brain-stem nuclei. Eur J Pharmacol 121:97-106
3. Baeyens JM, Esposito E, Ossowska G, Samanin R (1987) Effects of peripheral and central administration of calcium channel blockers in the naloxone-precipitated abstinence syndrome in morphine-dependent rats. Eur J Pharmacol 137:9-13
4. Barrios M, Baeyens JM (1988) Differential effects of calcium channel blockers and stimulants on morphine withdrawal in vilro. Eur J Pharmacol 152:175-178
5. Barrios M, Baeyens JM (1991) Differential effects of L-type calcium channel blockers and stimulants on naloxone-precipitated withdrawal in mice acutely dependent on morphine. Psychopharmacology 104:397-403
6. Barrios M, Robles I, Baeyens JM (1993) Role of L-type calcium channels on yohimbine-precipitated clonidine withdrawal in vivo and in vitro. Naunyn-Schmiedeberg's Arch Pharmacol 348:601-607
7. Bhargava HN (1978) The effects of divalent ions on morphine analgesia and abstinence syndrome in morphine-tolerant and - dependent mice. Psychopharmacology 57:223-225
8. Bongianni F, Carla V, Moroni F, Pellegrini-Giampietro DE (1986) Calcium channel inhibitors suppress the morphine-withdrawal syndrome in rats. Br J Pharmacol 88:561-567
9. Caro G, Barrios M, Baeyens JM (1988) Dose-dependent and stereo-selective antagonism by diltiazem of naloxone-precipitated morphine abstinence after acute morphine-dependence in vivo and in vitro. Life Sci 43: 1523-1527
10. Chapman DB, Way EL (1980) Metal ion interactions with opiates. Annu Rev Pharmacol Toxicol 20:553-579
11. Distefano P, Fox G, Johnson EM (1980) Characterization of the clonidine withdrawal syndrome in the normotensive rat. J Pharmacol Exp Ther 214:263-268
12. Dolin SJ, Little HJ (1989) Effects of nitrendipine on nitrous oxide anesthesia, tolerance and physical dependence. Anesthesiology 70:91-97
13. Dolin SJ, Patch TL, Rabbani M, Siarey RJ, Bowhay AR, Little HJ (1990) Nitrendipine decreases benzodiazepine withdrawal seizures but not the development of benzodiazepine tolerance or withdrawal signs. Br J Pharmacol 101:691-697
14. End DW, Carchman RA, Dewey WL (1981) Interactions of narcotics with synaptosomal calcium transport. Biochem Pharmacol 30:674-676
15. Garcia-Sevilla JA, Ahtee L, Magnusson T, Carlsson A (1978) Opiate-receptor mediated changes in monoamine synthesis in rat brain. J Pharm Pharmacol 30:613-621
16. 3H]dopa in various regions of the brain. J Neurochem 13:655-669
17. Harris RA, Loh HH, Way EL (1976) Antinociceptive effects of lanthanum and cerium in non tolerant and morphine tolerant-dependent-mice. J Pharmacol Exp Ther 196:288-297
18. Harris RA, Yamamoto H, Loh HH, Way EL (1977) Discrete changes in brain calcium with morphine analgesia, tolerance-dependence, and abstinence. Life Sci 20:501-506
19. Hosey HM, Lazdunski M (1988) Calcium channels, molecular pharmacology, structure and regulation. J Membr Biol 104:81-105
20. Jaw SP, Hoskins B, Ho IK (1993a) Involvement of δ-opioid receptors in physical dependence on butorphanol. Eur J Pharmacol 240:67-72
21. Jaw SP, Makimura M, Hoskins B, Ho IK (1993b) Effect of norbinaltorphimine on butorphanol dependence. Eur J Pharmacol 239:133-140
22. 2 receptors in rat substantia nigra neurones. J Physiol 401:437-453
23. Little HJ, Dolin SJ, Halsey MJ (1986) Calcium channel antagonists decrease the ethanol withdrawal syndrome. Life Sci 39:2059-2065
24. Littleton JM, Little HJ, Whittington MA (1990) Effects of dihydropyridine calcium channel antagonists in ethanol withdrawal: doses required, stereospecificity and actions of Bay K 8644. Psychopharmacology 100:387-392
25. Miller RJ (1981) Peptides as neurotransmitters: focus on the enkephalin and endorphins. Pharmacol Ther 12:73-108
26. Nishi K, Akaike N, Oyama Y, Ito H (1983) Actions of calcium antagonists on calcium currents in helix neurons: specificity and potency. Circ Res 52 [suppl I]: 53-59
27. North RA (1993) Opioid actions on membrane ion channels. In: Herz A (ed) Handbook of of experimental pharmacology (Opioids, vol. 104/1). Springer, Berlin Heidelberg New York, pp 773-797
28. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd edn. Academic Press, Orlando
29. Pothos E, Rada P, Mark GP, Hoebel BG (1991) Dopamine microdialysis in the nucleus accumbens during acute and chronic morphine, naloxone-precipitated withdrawal and clonidine treatment. Brain Res 566:348-350
30. Ramkumar V, El-Fakahany EE (1988) Prolonged morphine treatment increases rat brain dihydropyridine binding sites, possible involvement in development of morphine dependence. Eur J Pharmacol 146:73-83
31. + channel openers inhibit morphine withdrawal. Eur J Pharmacol 251:113-115
32. Rossetti ZL, Hmaidan Y, Gessa GL (1992) Marked inhibition of mesolimbic dopamine release: a common feature of ethanol. morphine, cocaine and amphetamine abstinence in rats. Eur J Pharmacol 221:227-234
33. Sanghvi IS, Gershon S (1976) Morphine dependent rats: blockade of precipitated abstinence by calcium. Life Sci 18:649-654
34. Sanghvi IS, Gershon S (1977) Brain calcium and morphine action. Biochem Pharmacol 26:1183-1185
35. 2+ channel blocker, diltiazem, prevents physical dependence and the enhancement of protein kinase C activity by opioid infusion in rats. Eur J Pharmacol 279:93-98
36. Tokuyama S, Feng YZ, Wakabayashi H, Ho IK (1995b) Possible involvement of protein kinases in physical dependence on opioids: studies using protein kinase inhibitors. H-7 and H-8. Eur J Pharmacol 284:101-107
37. Tsien RW, Lipscombe D, Madison DV, Bley KR, Fox AP (1988) Multiple types of neuronal calcium channels and their selective modulation. Trends Neurosci 11:431-437
38. Tytgat J, Vereecke J, Carmeliet E. (1988) Differential effects of verapamil and flunarizine on cardiac L-type and T-type Ca channels. Naunyn-Schmiedeberg's Arch Pharmacol 337: 690-692
39. 2+ channel function and drug action. Trends Pharmacol Sci 16:43-49
40. Wakabayashi H, Tokuyama S, Ho IK (1995) Simultaneous measurement of biogenic amines and their metabolites in rat brain regions after acute adminstration of and abrupt withdrawal from butorphanol or morphine. Neurochem Res 20:1179-1185
41. Wanger JA, Guggino SE, Reynolds IJ, Snowman AM, Biswas A, Olivera BM, Snyder SH (1988) Calcium antagonist receptors. Clinical and physiological relevance. Ann NY Acad Sci 522:116-133
42. Watson WP, Little HJ (1994) Interactions between diltiazem and ethanol: differences from those seen with dihydropyridine calcium channel antagonists. Psychopharmacology 114:329-336
43. Yamamoto H, Harris RA, Loh HH, Way EL (1978) Effects of acute and chronic morphine treatments on calcium localization and binding in brain. J Pharmacol Exp Ther 205:255-264